A double-blind, parallel, comparative evaluation of amlodipine vs. captopril in the monotherapeutic treatment of mild and moderate essential hypertension
| Autor: | Otto Hernandez Pieretti, Honorio Silva, Rafael Hernández Hernández, Ricardo Fonseca, Adalberto Urbina, Manuel Velasco, José Guevara |
|---|---|
| Rok vydání: | 1991 |
| Předmět: |
Adult
Male Supine position Captopril Blood Pressure Essential hypertension Severity of Illness Index Drug Administration Schedule Double-Blind Method Heart rate medicine Humans Amlodipine Adverse effect Antihypertensive Agents Aged Pharmacology business.industry Middle Aged Interim analysis medicine.disease Blood pressure Anesthesia Hypertension Female Cardiology and Cardiovascular Medicine business medicine.drug |
| Zdroj: | Journal of cardiovascular pharmacology. 17 |
| ISSN: | 0160-2446 |
| Popis: | A double-blind, parallel, comparative study of the antihypertensive efficacy and safety of once-daily oral doses of amlodipine (5-10 mg/day) vs. twice-daily oral doses of captopril (25-50 mg twice daily) in adult patients with mild or moderate essential hypertension (supine diastolic blood pressure of 95-115 mm Hg) was undertaken in two hospital centers. Interim analysis of data from 40 patients shows that amlodipine and captopril both significantly (p < 0.05) reduced blood pressure compared with baseline. Nineteen of 21 (90.5%) amlodipine-treated patients and 15 of 19 (78.9%) captopril-treated patients had their diastolic blood pressure "normalized" (< 90 mm Hg) with mean final doses of 8.2 and 76.7 mg/day, respectively. At the final visit, there were no statistically significant differences between the two treatment groups in either mean supine or standing blood pressure. Minor nonsignificant changes in standing heart rate were observed in both treatment groups. Seven of the 21 amlodipine-treated patients and 3 of the 19 captopril-treated patients reported adverse experiences. No patients in either treatment group discontinued due to adverse events; one patient in the amlodipine group required a dose reduction. These interim data indicate that the overall efficacy and safety profiles of these two drugs are comparable. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|